Related Experiment Videos

The pattern of fungal infections in critically ill surgical patients

E E Cornwell1, H Belzberg, T V offne

  • 1Los Angeles County + University of Southern California Medical Center 90033-4525, USA.

The American Surgeon
|October 1, 1995
PubMed

Insights

Distinguishing fungal colonization from systemic infection in critically ill surgical patients is challenging. Systemic fungal infections significantly increase mortality, but no single culture site reliably predicts this outcome.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Clinical differentiation between fungal colonization and systemic infection in critically ill surgical patients remains difficult.
  • Aggressive antifungal therapy carries potential risks, necessitating accurate diagnosis.

Purpose of the Study:

  • To evaluate the significance of fungal infections originating from various sites in critically ill surgical patients.
  • To determine if any single culture site is superior in predicting systemic fungal infection.

Main Methods:

  • Retrospective review of clinical courses of patients with fungal cultures positive for Candida or Torulopsis glabrata.
  • Analysis of data from the Surgical Intensive Care Unit (SICU) at LAC + USC Medical Center (January 1992-December 1993).
  • Comparison of outcomes, including mortality, based on the presence and site of fungal isolation.

Main Results:

  • 129 patients had positive fungal cultures (Candida or Torulopsis glabrata).
  • 43% of patients developed systemic fungal infections (two or more sites, or fungemia).
  • Systemic fungal infection significantly increased SICU mortality (36.3% vs. 10.5%, P < 0.05), while single-site isolation did not (13.5% vs. 10.5%, P = 0.52).

Conclusions:

  • Systemic fungal infection is associated with increased mortality in SICU patients.
  • No single site of fungal isolation reliably predicts the development of systemic infection.
  • Prospective studies investigating less toxic antifungal agents for patients with single-site isolation are warranted.

Related Concept Videos